Mechanisms of neuronal death during development - Insights from chick motoneurons

In Vivo

Volumn 14, Issue 1, 2000, Pages 61-82

  Milligan, Carolanne E ^a   Li, Ling ^a   Barnes, Natalie Y ^a   Urioste, Alexander S ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Chick motoneurons; Development; Neuronal death

Indexed keywords

CASPASE; CLUSTERIN; FAS LIGAND; PROTEIN P75; TYROSINE KINASE RECEPTOR;

APOPTOSIS; BIOLOGICAL MODEL; CELL DEATH; CHICKEN; HUMAN; MOTONEURON; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; ONCOGENE C FOS; ONCOGENE C JUN; OXIDATIVE STRESS; PHAGOCYTE; PROTEIN EXPRESSION; REVIEW;

EID: 0034026398     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (236)

1. Beard J: The history of a transient nervous apparatus in certain Ichthyopsida. An account of the development of ganlion cells and nerve fibers. Zool Jahrbucher Abt Morphol 9: 1-106, 1896.
2. Collin: Recherches cytologiques sur le developpement de la cellule nerveuse. Nevraxe 8: 181-308, 1906.
3. Ernst M: Uber untergang von zellen warhrend der normalen entwicklung bei wirbeltieren. Z Anal Entwicklungsgesch 79: 228-262, 1926.
4. Glucksman: Ueber die Bedeutung von Zellvorgangen fur die Formbildung epithelialer Organe. Zeitsch Anat u Entw gesch 93: 35-92, 1930.
5. Hamburger V and Levi-Montalcini R: Proliferation, differentiation in the spinal ganglia of the chick embryo under normal and experimental conditions. J Exp Zool 111: 457-501, 1949.
6. Hankin M, Schneider B, Silver J: Death of the subcallosal glial sling is correlated with the formation of the cavum septi pellucidi. J Comp Neurol 272: 191-202, 1988.
7. Barres BA, Hart IK, Coles HS, Bume JF, Voyvodic JT, Richardson WD, Raff MC: Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70: 3146, 1992.
8. Cuitat D, Caldero J, Oppenheim RW, Esquerda JE: Schwann cell apoptosis during normal development and after axonal degeneration induced by neurotoxins in the chick embryo. J Neurosci 16: 3979-3990, 1996.
9. Cunningham TJ: Naturally occurring neuron death and its regulation by developing neuronal pathways. International Review of Cytology 74: 163-186, 1982.
10. Cowan WM, Fawcett JW, O'Leary DDM, Stanfield BB: Regressive events in neurogenesis. Science 225: 1258-1265, 1984.
11. Oppenheim RW: Cell death during development of the nervous system. Annu Rev Neurosci 14: 453-501, 1991.
12. Henderson CE: Programmed cell death in the developing nervous system. Neuron 17: 579-85, 1996.
13. Hamburger V and Levi-Montalcini R: Some aspects of neuroembryology. In: Genetic Neurobiology (P. Weiss, ed). Chicago, IL, University of Chicago Press, 1950, pp 125-160.
14. Levi-Montalcini R: Effects of mouse tumor transplantation on the nervous system. Ann NY Acad Sci 55: 330-344, 1952.
15. Hamburger V: Regression versus peripheral control of differentiation in motor hypoplasia. Am J Anat 102: 365-410, 1958.
16. Hollyday M and Hamburger V: Reduction of the naturally occurring motor neuron loss by enlargement of the periphery. J Comp Neurol 170: 311-20, 1976.
17. Hamburger V and Oppenheim RW: Naturally ocurring neuronal death in vertebrates. Neurosci Comment 1: 39-55, 1982.
18. Clarke PGH: Apoptosis versus necrosis. In: Cell death in diseases of the nervous system (Koliatsos V and Rata R, eds). Ttoowa, NY, Humana Press, Inc. 1997, pp 3-28.
19. Greene LA: Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium. J Cell Biol 78: 747-55, 1978.
20. Rukenstein A, Rydel RE, Greene LA: Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms. J Neurosci 11: 2552-63, 1991.
21. Levi-Montalchini R and Angeletti PU: Essential role of nerve growth factor in the survival and maintenance of dissociated sensory and sympathetic embryonic nerve cells in vitro. Dev Biol 7: 653-659, 1963.
22. Johnson MI and Argiro V: Techniques in the tissue culture of rat sympathetic neurons. Methods Enzymol 103: 334-47, 1983.
23. Martin DP, Schmidt RE, Distefano PS, Lowry OH, Carter JG, Johnson Jr EM: Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol 106: 829-844, 1988.
24. Deckwerth TL and Johnson Jr EM: Neurotrophic factor deprivation-induced death. Ann N Y Acad Sci 679: 121-31, 1993.
25. Hollyday M and Hamburger V: An autoradiographic study of the formation of the lateral motor column in the chick embryo. Brain Res 132: 197-208, 1977.
26. Lance-Jones C and Landmesser L: Motoneurone projection patterns in the chick hind limb following early partial reversals of the spinal cord. J Physiol 302: 581-602, 1980.
27. Lance-Jones C and Landmesser L: Pathway selection by chick lumbosacral motoneurons during normal development. Proc R Soc Lond 214: 1-18, 1981.
28. Mettling C, Gouin A, Robinson M, el M'Hamdi H, Camu W, Bloch-Gallego E, Buisson B, Tanaka H, Davies AM, Henderson CE: Survival of newly postmitotic motoneurons is transiently independent of exogenous trophic support. J Neurosci 15: 3128-37, 1995.
29. Milligan CE, Oppenheim RW, Schwartz LM: Motoneurons deprived of trophic support in vitro require new gene expression to undergo programmed cell death. J Neurobiol 25: 1005-1016, 1994.
30. Loekshin RA and Williams CM: Programmed cell death: Cytology of degeneration in the intersegmental muscles of the silkmoth. J Insect Physiol 11: 123-33, 1965.
31. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide- ranging implications in tissue kenetics. Br J Cancer 26: 239-257, 1972.
32. Sumali A, Zhivtovsky B, Jones D, Nagata S, Orrenlius S: Apoptosis: Cell death defined by caspases activation. Cell Death Diff 6: 495-496, 1999.
33. Pilar G and Landmesser L: Ultrastructural differences during embryonic cell death in normal and peripherally deprived ciliary ganglia. J Cell Biol 68: 339-356, 1976.
34. Chu-Wang I-Wu and Oppenheim RW: Cell death of motoneurons in the chick embryo spinal cord. I. A light and electron microscopic study of naturally occurring and induced cell loss during development. J Comp Neur 177: 33-58, 1978.
35. Oppenheim RW, Prevette D, Tytell M, Homa S: Naturally occurring and induced neuronal death in the chick embryo in vivo requires protein and RNA synthesis: evidence for the role of cell death genes. Dev Biol 138: 104-113, 1990.
36. Estus S, Zaks WJ, Freeman RS, Gruda M, Bravo R, Johnson Jr EM: Altered gene expression in neurons during programmed cell death: Identification of cjun as necessary for neuronal apoptosis. J Cell Biol 127: 1717-27, 1994.
37. Freeman RS, Estus S, Johnson Jr EM: Analysis of cell cycle-related gene expression in postmitotic neurons:sclective induction of cyclin D1 during programmed cell death. Neuron 12: 343-355, 1994.
38. Mesner PW, Epting CL, Hegarty JL, Green SH: A timetable of events during programmed cell death induced by trophic factor withdrawal from neuronal PC12 cells. J Neurosci 15: 7357-7366, 1995.
39. ∼ckman P, Dragunow M Do c-Jun, c-Fos, and amyloid precursor protein play a role in neuronal death or survival? J Neurosci Res 53: 33042, 1998.
40. Ham J, Babij C, Whitficld J, Pfarr CM, Lallemand D, Yaniv M, Rubin LL: A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14: 927-39, 1995.
41. Borovitskaya AE and Evtushenko VI: Gamma-radiation-induced cell death in the fetal rat brain possesses molecular characteristics of apoptosis and is associated with specific messenger RNA elevations. Brain Res Mol Brain Res 35: 19-30, 1996.
42. Ferrer I, Olive M, Ribera J, Planas AM: Naturally occurring (programmed) and radiation- induced apoptosis are associated with selective c-Jun expression in the developing rat brain. Eur J Neurosci 8: 1286-98, 1996.
43. Ferrer I, Olive M, Blanco R, Cinos C, Planas AM Selective c-Jun overexpression is associated with ionizing radiation-induced apoptosis in the developing cerebellum of the rat. Brain Res Mol Brain Res 38: 91-100, 1996.
44. Ayala V, Casas C, Ribera J, Caldero J, Oppenheim RW, Esquerda JE: Specific association of c-Jun-like immunoreactivity but not c-Junp39 with normal and induced programmed cell death in the chick embryo. J Neurobiol 38: 171-90, 1999.
45. Estus S, Tucker HM, van Rooyen C, Wright S, Brigham EF, Wogulis M, Rydel RE: Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant "apoptotic" pattern of gene induction. J Neurosci 17: 7736-45, 1997.
46. Ferrer I, Pozas E, Marti M, Blanco R, Planas AM Methylazoxymethanol acetate-induced apoptosis in the external granule cell layer of the developing cerebellum of the rat is associated with strong c-Jun expression and formation of high molecular weight c-Jun complexes. J Neuropathol Exp Neurol 56: 1-9, 1997.
47. Oo TF, Henchcliffe C, James D, Burke RE: Expression of c-fos, cjun, and cjun N-terminal kinase (JNK) in a developmental model of induced apoptotic death in neurons of the substantia nigra. J Neurochem 72: 557-64, 1999.
48. Roffler-Tarlov S, Brown JJ, Tarlov E, Stolarov J, Chapman DL, Alexiou M, Papaioannou VE: Programmed cell death in the absence of c-Fos and c-Jun. Development 122: 1-9, 1996.
49. Schlingensiepen KH, Wollnik F, Kunst M, Schlingensiepen R, Herdegen T, Brysch W: The role of Jun transcription factor expression and phosphorylation in neuronal differentiation, neuronal cell death, and plastic adaptations in vivo. Cell Mol Neurobiol 14: 487-505, 1994.
50. Hughes PE, Alexi T, Walton M, Williams CE, Dragunow M, Clark RG, Gluckman PD: Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system. Prog Neurobiol 57: 421-50, 1999.
51. Le-Niculescu H, Bonfoco E, Kasuya Y, Claret FX, Green DR, Karin M: Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol Cell Biol 19: 751-63, 1999.
52. Maroney AC, Glicksman MA, Basma AN, Walton KM, Knight E Jr, Murphy CA, Barlett BA, Finn JP, Angeles T, Matsuda Y, Neff NT, Dionne CA: Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J Neurosci 18: 104-11, 1998.
53. Harada J and Sugimoto M: An inhibitor of p38 and JNK MAP kinases prevents activation of caspase and apoptosis of cultured cerebellar granule neurons. Jpn J Pharmacol 79: 369-78, 1999.
54. Buttyan R, Olsson CA, Pintar J, Chang C, Bandyk M, Ng P-Y, Sawczuk IS: Induction of the TRPM-2 gene in cells undergoing programmed cell death. Mol Cell Biol 9: 3473-3481, 1989.
55. May PC and Finch CE: Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration. TINS 15: 391-6, 1992.
56. Garden GA, Bothwell M, Rubel EW: Lack of correspondence between mRNA expression for a putative cell death molecule (SGP-2) and neuronal cell death in the central nervous system. J Neurobiol 22: 590-604, 1991.
57. Martin DP, Ito A, Horigome K, Lampe P, Johnson, Jr. EM: Biochemical characterization of programmed cell death in NGF-deprived sympathetic neurons. J Neurobiol 23: 1205-20, 1992.
58. D'Mello SR and Galli C: SGP2, ubiquitin, 14K lectin and RP8 mRNAs are not induced in neuronal apoptosis. Neuro Report 4: 355-58, 1993.
59. O'Bryan MK, Cheema SS, Bartlett PF, Murphy BF, Pearse MJ: Clusterin levels increase during neuronal development. J Neurobiol 24: 421-32, 1993.
60. Weiner C, Back T, Bonnekoh P, Kohno K, Gehrmann J, Hossman K-A: Sulfated glycoprotein-2 mRNA in the rat brain following transient forebrain ischemia. Mol Brain Res 20: 345-52, 1993.
61. Norman DJ, Feng L, Cheng SS, Gubbay J, Chan E, Heintz N: The lurcher gene induces apoptotic death in cerebellar Purkinje cells. Development 121: 1183-93, 1995.
62. Jomary C, Darrow RM, Wong P, Organisciak DT, Neal MJ, Jones SE: Lack of causal relationship between clusterin expression and photoreceptor apoptosis in light-induced retinal degeneration. J Neurochem 72: 1923-9, 1999.
63. Rozovsky I, Morgan TE, Willoughby DA, Dugich-Djordjevich MM, Pasinetti GM, Johnson SA, Finch CE: Selective expression of clusterin (SGP-2) and complement ClqB and C4 during responses to neurotoxins in vivo and in vitro. Neurosci 62: 741-58, 1994.
64. Dragunow M, Preston K, Dodd J, Young D, Lawlor P, Christie D: Clusterin accumulates in dying neurons following status epilepticus. Mol Brain Res 32: 279-90, 1995.
65. Barnes NY, Li L, Yoshikawa K, Schwartz LM, Oppenheim RW, Milligan CE: Increased production of the amyloid precurosr serves as a substrate for Caspase-3 in dying motoneurons. J Neurosci 18: 5869-5880, 1998.
66. Weidemann A, Paliga K, Durrwang U, Reinhard FBM, Schuckert O, Evin G, Masters CL: Proteolytic processing of the Alzheimer's Disease Amyloid Precursor Protein withinn its cytoplasmic domain by Caspase-like proteases. J Biol Chem 274: 5823-5829, 1999.
67. Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J, LeBlanc Ai Smith D, Rigby M, Shearman MS, Clarke EE, Zheng H, Van Der Ploeg LH, Ruffolo SC, Thornberry NA, Xanthoudakis S, Zamboni RJ, Roy S, Nicholson DW: Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 97: 395406, 1999.
68. Araki W and Wurtman RJ: Increased expression of amyloid precursor protein and amyloid precursor-like protein 2during trophic factor withdrawal-induced death of neuronal PC12 cells. Brain Res Mol Brain Res 56: 169-77, 1998.
69. Kawarabayashi T, Shoji M, Harigaya Y, Yamaguchi H, Hirai S: Expression of APP in the early stage of brain damage. Brain Res 563: 334-8, 1991.
70. Gehrmann J, Banati RB, Cuzner ML, Kreutzberg GW, Newcombe J: Amyloid precursor protein (APP) in multiple sclerosis lesions. Glia 15: 141-151, 1995.
71. Sasaki S and Iwata M: Immunocytochemical and ultrastructulal study of pericapillary rosettes in amyotrophic lateral sclerosis. Acta neuropathol 94: 338-344, 1997.
72. Shannon P, Smith CR, Deck J, Ang LC, Ho M, Becker L: Axonal injury and the neuropathology of shaken baby syndrome. Acta neuropath 95: 625-631, 1998.
73. Ichihara N, Wu J, Chui DH, Yamazaki K, Wakabayashi T, Kikuchi T: Axonal degeneration promotes abnormal accumulation of amyloid-beta protein in ascenting gracile tract of gracile axonal dystrophy (GAD) mouse. Brain Res 695: 173-178, 1995.
74. Komori N, Kittel A, Kang D, Shackelford D, Masliah E, Zivin JA, Saitoh T: Reversible ischemia increases levels of Alzheimer amyloid protein precursor without increasing levels of mRNA in the rabbit spinal cord. Mol Brain Res 49: 103-112, 1997.
75. Ahlgren S, Li GL, Olsson Y: Accumulation of B-amyloid precursor protein and ubiquitin in axons after spinal cord trauma in humans: immunohistochemical observations on autopsy material. Acta Neuropath 92: 49-55, 1996.
76. Li P, Allen H, Banerjee S, Franklin S et al: Mice deficient in IL-1β converting enzyme arc defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80: 401-412, 1995.
77. Selkoe DJ: Physiological production for the β-amyloid protein and the mechanism of Alzheimer's disease. TINS 16: 403-409, 1993.
78. Haass C and Selkoe DJ: A technical KO of amyloid-β peptide. Nature 391: 339-340, 1998.
79. Mattson MP: Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77: 1081-132, 1997.
80. Sola C, Garcia-Ladona FJ, Sarasa M, Mengod G, Probst A, Palacios G, Palacios JM: BAPP gene expression is increased in the rat brain after motor neuron axotomy. Euro J Neurosci 5: 795-808, 1993.
81. Cotman CW and Anderson AJ: A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol Neurobiol 10: 1945, 1995.
82. Barinaga M: Is apoptosis key in Alzeheimer's Disease? Science 281: 1301-1302, 1998.
83. Yankner BA: Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16: 921-932, 1996.
84. De Strooper B, Saftig P, Gaessaerts K, Vanderstichele H, Guhde G, Annaert W, Von Figura K, Van Leuven F: Deficiency of presinilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391: 387-390, 1998.
85. Yankner BA, Duffy LK, Kirschner DA: Neurotrophic and neurotoxic effects of Amyloid protein: Reversal by Tachykinin neuropeptides. Science 250: 279-282, 1990.
86. LeBlanc A: Increased production of 4 kDa amyloid β peptide in serum deprived human primary neuron cultures: Possible involvement of apoptosis. J Neurosci 15: 7837-46, 1995.
87. Anderson AJ, Pike CJ, Cotman CW: Differential induction of immediate early gene proteins in cultured neurons by β-Amyloid (Aβ): Association of c-Jun with Aβ-induced apoptosis. J Neurochem 65: 1487-1498, 1995.
88. Le W-D, Colom LV, Xie Wj, Smith RG, Alexianu M, Appel SH: Cell death induced by amyloid 1-40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis. Brain Res 686: 49-60, 1995.
89. Paradis E, Douillard H, Koutroumanis M, Goodyer C, LeBlanc A: Amyloid β peptide of Alzheimer's disease downregulates Bcl-2 and upregulates Bax expression in human neurons. J Neurosci 16: 7533-9, 1996.
90. Bozyczko-Coyne D, McKenna BA, Siman R: Caspase mediation of Aβ neurotoxicity in vitro. Soc Neurosci Abs 23: 1628, 1997.
91. Suzuki A: Amyloid beta-protein induces necrotic cell death mediated by ICE cascade in PC12 cells. Exp Cell Res 234: 507-511, 1997.
92. Li L, Prevette D, Oppenheim RW, Milligan CE: Multiple caspases are involved in motoneuron cell death. Mol Cell Neurosci 12: 157-67, 1998.
93. Ellis HM and Horvitz HR: Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cell 44: 817-29, 1986.
94. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75: 641-52, 1993.
95. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thomberry NA, Wong WW, Yuan J: Human ICE/CED-3 protease nomenclature. Cell 87: 171, 1996.
96. Thomberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Ellison KO, Ayala JM, Casano FJ, Chin J, Ding GJ-F, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju Sm, Ralando AM, Salley JP, Yamin T-T, Lee TD, Shively JE, MacCross M, Mumford RA, Schmidt JA, Tocci MJ: A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356: 768-74, 1992.
97. Schwartz LM and Milligan CE: Cold thoughts of death: the role of ICE proteasees in neuronal cell death. TINS 19: 555-62, 1996.
98. Gagliardini V, Fernandez P-A, Lee RKK, Drexler HCA, Rotello RJ, Fishman MC Yuan J: Prevention of vertebrate neuronal death by the CnnA gene. Science 263: 826-8, 1994.
99. Milligan CE, Webster L, Piros ET, Evans CE, Cunningham TJ, Levitt P: An Opioid Chemotactic Factor Mediates the Targeting of Macrophages to the Site of Injury- Induced Neuronal Cell Death in the Developing Brain. J Immunol 154: 6571-6581, 1995.
100. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H, Rakic P, and Flavell RA: Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384: 368-372, 1996.
101. Kuida K, Haydar TF, Kuan C-Y, Gu Y, Taya C, Karasuyama H, Su M S-S, Rakic P, Flavell RA: Reduced apoptosis and cytochrome c-mediated caspase acdvation in mice lacking Caspasc 9. Cell 94: 325-337, 1998.
102. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi K, Khoo W: Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94: 339-352, 1998.
103. Bergeron L, Perez GI, Macdonald G, Shi L, Sun Y, Jurisicova A, Varmuza S, Latham KE, Flaws JA, Salter JC: Defects in regulation of apoptosis in caspase2-deficient mice. Genes Dev 12: 1304-1314, 1998.
104. Eldadah BA, Yakovlev AG, Faden AI: The role of CED-3-related cysteine proteases in apoptosis of cerebellar granule cells. J Neurosci 17: 6105-6113, 1997.
105. Yakovlev AG, Knoblach SM, Fan L, Fox GB, Goodnight R, Faden AI: Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J Neurosci 17: 7415-7424, 1997.
106. Stefanis L, Burke RE, Greene LA: Apoptosis in neurodegenerative disorders. Curr Opin Neurol 10: 299-305, 1997.
107. Troy CM, Stefanis L, Greene LA, Shelanske ML: Nedd2 is required for apoptosis after trophic factor withdrawal but not superoxide dismutase (SOD1) downregulation in sympathetic neurons and PC12 cells. J Neurosci 17: 1911-1918, 1997.
108. Enari M, Hug H, Nagata S: Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375: 78-81, 1995.
109. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489, 1997.
110. Caldero J, Prevette D, Mei X, Oakley RA, Li L, Milligan CE, Houenou L, Burck M, Oppenheim RW: Peripheral target regulation of the development and survival of spinal sensory and motor neurons in the chick embryo. J Neurosci 18: 356-370, 1998.
111. Milligan CE, Shiraiwa N, Prevette D, Li L, Momoi T, Oppenheim RW: Motoneuron death following limb-bud removal (LBR) is independent of caspase activity and distinct from naturally occurring motoneuron death. Society for Neuroscience Abstracts 25: 1525, 1999.
112. Miller TM, Mouder KL, Knudson CM, Creedon DJ, Deshmukt Mj Korsmeyer Sj, Johnson EM: Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway t ocell death. J Cell Biol 139: 205-217, 1997.
113. Cohen GM: Caspases: The executioners of apoptosis. Biochem J 326: 1-16, 1997.
114. Cardone MH, Salvesen GS, Widmann C, Hohnson G, Frisch SM: The regulation of anoikis: MEKK1 activation requires cleavage by caspases. Cell 90: 315-323, 1997.
115. Widann C, Gerwins P, Johnson NL, Jarpe MB, Johnson GC: MEK kinasel a substitute for DEVD-directed caspases, in involved in genotoxin-induced apoptosis. Mol Cell Biol 18: 2419-29, 1998.
116. Graves DT, Jiang YL, Williamson MJ, Valente AJ: Identification of monocyte chemotactic activity produced by malignant cells. Science 245: 1490-1493, 1989.
117. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-90, 1998.
118. Grass A, Jockel J, Wei MC, Korsmeyer SJ: Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 14: 3878-3885, 1998.
119. Li H, Zhu H, Xu CJ, Yuan J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501, 1998.
120. An B and Dou QP: Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate. Cancer Res 56: 438-42, 1996.
121. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG: Specific proteolytic cleavage of poly(ADP-ribose) polymerasc: an early marker of chemotherapy-induced apoptosis. Cancer Res 53: 3976-3985, 1993.
122. Sanghavi DM, Telen M, Thornberry NA, Casciola-Rosen L, Rosen A: Caspase-mediated proteolysis during apoptosis: insights from apoptotic ncutrophils. FEBS Lett 422: 179-84, 1998.
123. Casciola-Rosen LA, Miller DK, Anhalt GJ, Rosen A: Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of 7 apoptotic cell death. Biol Chem 269: 30757-60, 1994.
124. Rheaume E, Cohen LY, Uhlmann F, Lazura C: The large subunit of replication factor C is a substrate for caspase-3 in vitro and is cleaved by a caspase-3-like protease during FAS- mediated apoptosis. EMBO J 16: 6346-54, 1997.
125. Rao L, Perez D, White E: Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol 135: 1441-55, 1996.
126. Mashima T, Naito M, Noguchi K, Miller DK, Nicholson DW, Tsuruo T: Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene 14: 1007-12, 1997.
127. Brown SB, Bailey K, Savill J: Actin is cleaved during constitutive apoptosis. Biochem J 323: 233-7, 1997.
128. Mashima T, Naito M, Tsuruo T: Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis. Oncogcne 18: 2423-30, 1999.
129. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ,- Kirschner MW, Koth SK, Kwiatkowski DJ: Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278: 294-8, 1997.
130. Canu N Dus L, Barbato C, Ciotti MT, Brancolini C, Rinaldi AM, Novak M, Cattaneo A, Bradbury A, Calissano P: Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J Neurosci 18: 7061-74, 1998.
131. Rudel T and Bokoch GM: Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276: 1571-1574, 1997.
132. Fernandes-Alnemri T, Litwack G, Alnemri ES: CPP32, a novel human apoptotic protein with homology to caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269: 30761-30764, 1994.
133. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffen PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK: Identification and inhibition of the ICElCed-3 protease necessary for mammalian apoptosis. Nature 376: 37-43, 1995.
134. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Dixit VM Yama/CPP32B, a mammalain homolog of Ced-3, is a crmA-inhibitable protease that cleaves tlie death substrate poly(ADP-ribose) polymerase. Cell 81: 801-809, 1995.
135. Salvesen GS and Dixit VM: Caspases: intracellular signalling by proteolysis. Cell 91: 443-6, 1997.
136. Porter AG, Janicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Diff. 6: 99-104, 1999.
137. L has activity independent of cytochrome c release. Biol Chem 272: 30299-305, 1997.
138. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X: Apaf-1, a human protein homologous to C.elegans CED4. participates in cytochrome C-dependent activation of caspase-3. Cell 90: 405-413, 1997.
139. Li L, Oppenheim RW, Milligan CE: Characterization of the execution pathway in motoneurons deprived of trophic support. Submitted.
140. Jacobson BA, Panka DJ, Nguyen KA, Erikson J, Abbas AK, Marshak-Rothstein A Anatomy of autoantibody production: dominant localization of antibody-producing cells toT cell zones in Fas-deficient mice. Immunity 3: 509-19, 1995.
141. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR, Cohen GM: Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 274: 5053-5060, 1999.
142. Susin SA, Zamzami N, Kroemer G: Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta 1366: 151-65, 1998.
143. Krajewski S, Krajewska M, Ellerby LM, Welsh K, Xie Z, Deveralux QC, Salvesen GS, Bredesen DE: Release of caspase-9 from mitochondria during neuronal apoptosis and cereg\bral ischemia. Proc Natl Acad USA 96: 5752-5757, 1999.
144. Sanchez I, Xu CJ, Juo P, Kakizaka A, Blenis J, Yuan J: Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22: 623-33, 1999.
145. Tsujimoto Y, Ikegaki N, Croce CM: Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma. Oncogene 2: 3-7, 1987.
146. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Wpstein AL, Korsmeyer SJ: Cloning the chromosomal breakpoint of t(14,18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41: 889-906, 1985.
147. Cleary ML, Smith SD, Sklar J: Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoblobulin transcript resulting from the t(14:18) translocation. Cell 47: 19-28, 1986.
148. Chao DT and Korsmeyer SJ: Bcl-2 family: regulators of cell death. Annu Rev Immunol 16: 395-419, 1998.
149. Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ: bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120: 301-311, 1994.
150. Martinou JC, Frankowski H, Nissotten M, Martinou I, Potter L, Dubois-Dauphic M: Bcl-2 and neuronal selection during development of the nervous system. J Physiol Paris 88: 209-11, 1994.
151. Castern E, Ohga Y, Berzaghi MP, Tzimagiorgis G, Thoenen H, Lindholm D: bcl-2 messenger RNA is localized in neurons of the developing and adult rat brain. Neurosci 61: 165-177, 1994.
152. Gonzalez-Garcia M, Garcia I, Ding L, O'Shea S, Boise LJ: bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci USA 92: 4304-4308, 1995.
153. Frankowski H, Missotten M, Fernandez PA, Martinou I, Michel P: Function and expression of the Bcl-x gene in the developing and adult nervous system. Neuroreport 6: 1917-1921, 1995.
154. Vekrellis K, McCarthy MJ, Watson A, Whitfield J, Rubin LL, Ham J: Bax promotes neuronal cell death and is downregulated during the development of the nervous system. Development 124: 123949, 1997.
155. Garcia I, Martinou I, Tsujimoto Y, Martinou JC: Prevention of programmed cell death of sympathetic neurons by the bcl-2 protoncogene. Science 258: 302-304, 1992.
156. Allsopp TE, Wyatt S, Paterson HF, Davies AM: The protooncogene bcl-2 can selectively rescure neurotrophic factor-dependent neurons from apoptosis. Cell 73: 295-307, 1993.
157. Sato N, Wang S, Li L, Okabe K, Hashimoto M, Yaginuma H, Mikoshiba K, Uchiyama Y, Uetsuki T, Yoshikawa K, Milligan CE, Oppenheim RW: A novel strategy for introducing exogenous Bcl-2 into neuronal cells: the Cre/loxP system-mediated activation of Bcl-2 for preventing programmed cell death using recombinant adenoviruses. Mol Cell Neurosci 12: 65-78, 1998.
158. Mah SP, Zhong LT, LIu Y, Roghani A, Edwards RH, Bredesen DE: The protooncogene bcl- 2 inhibits apoptosis in PC12 cells. J Neurochem 60: 1183-1186, 1993.
159. Batistatou A, Merry DE, Korsmeyer SJ, Greene LA: Bcl-2 affects survival but not neuronal defferentiation of PC12 cells. J Neurosci 13: 4422-4428, 1993.
160. Kane DJ, Ord T, Anton R, Bredesen DE: Expression of bcl-2 inhibits necrotic neural cell death. J Neurosci Res 40: 269-275, 1995.
161. Michaelidis TM, Sendtner M, Cooper JD, Airaksinen MS, Joltmann B, Meyer B, Thoenen H: Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Neuron 17: 75-89, 1996.
162. Motoyama N, Want F, Roth KA, Sawa H, Nakayama K, Nakayama K, Negishi I, Senju S, Zhang Q, Jujii S, Loh DY: Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267: 1506-1510, 1995.
163. Knudson CM, Tung KSK, Tourtellotte WG, Brown GAJ, Korsmeyer SJ: Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270: 96-99, 1995.
164. Deckwerth TL, Elliott JL, Kundson CM, Johnson EM, Snider WD, Korsmeyer SJ: Bax is required for neuronal death after trophic factor deprivation and during development. Neuron 17: 401-411, 1996.
165. Gleichmann M, Beinroth S, Reed JC, Krajewski S, Schulz JB, Wüillner U, Klockgether T, Weller M: Potassium deprivation-induced apoptosis of cerebellar granule neurons: Cytochrome c release in the absence of altered expression of Bcl-2 family proteins. Cell Physiol Biochem 8: 194-201, 1998.
166. Chaudhary P, Ahmed F, Quebada P, Sharma SC: Caspase inhibitors block the retinal gangion cell death following optic nerve transaction. Brain Res Mol Res 67: 36-45, 1999.
167. Guarin E, Seuret P, Nef S, deBibao F, Net P, Dubois-Dauphin M: cpp32 messemger RNA neosynthesis is induced by fatal axotomy and is not regulated by athanatal Bcl-2 over espression. Neurosci 96: 653-664, 1999.
168. Cellerino A, Michaelidis T, Barski JJ, Bahr M, Thoenen H, Meyer M Retinal ganglion cell loss after the perod of naturally occurring cell death in bcl-2-/- mice. Neuroport 10: 1091-1095, 1999.
169. Alberi S, Raggenbass M, de Bilbao F, Dubois-Dauphin M: Axotomized neonatal motoneurons overexpressing the bcl2 protooncogene retainfunctional electrophysiological properties. Proc Natl Acad Sci USA 93: 3978-83, 1996.
170. Offen D, Beart PM, Cheung NS, Pascoe CJ, Hochman A, Gorodin S, Melamed E, Bemard R, Bemard O: Transgenic mice expressing human Bcl-2 in thier neurons are resistant to 6- hydroxydopamine and 1-methyl4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Proc Natl USA 95: 5789-5794, 1998.
171. Parsadanian AS, Cheng Y, Keller-Peck CR, Holtzman DM, Snider WD: Bcl-XL is an antiapoptotic regulator for postnatal CNS neurons. J Neurosci 18: 1009-1019, 1998.
172. Isenmann S, Engel S, Gillardon F, Bahr M: Bax antisense oligonucleotides reduce axotomy- induced retina Iganglion cell deth in vivo by reduction of Bzx protein expression. Cell Death Diff 6: 673-682, 1999.
173. Muchmore SW: X-ray and NMR struture of human bcl-Xl, an inhibitor of programmed cell death. Nature 381: 335-341, 1996.
174. Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, Martinou I, Bemasconi L, Bemard A, Mermod JJ, Mazzei G: Inhibition of Bax chennel-forming activity by Bcl-2. Science 277: 370-372, 1997.
175. Minn AJ, Velez P, Schendel SL, Liang H, Muchmore SW, Fesik SW, Fill SW, Thompson CB: Bcl-X(L) forms an ion channel in synthetic lipid membranes. Nature 385: 353-357, 1997.
176. Schendel SL, Xie Z, Montal MO, Matsuyama S, Montal M, Reed JC: Channel formation by antiapoptotic protein Bcl-2. Proc Natl Acad Sci USA 94: 5113-5118, 1997.
177. Nguyen M, Millar DG, Yong VW, Korsmeyer SJ, Shore GC: Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal sequence. J Biol Chem 269: 16521-16524, 1993.
178. Gonalez-Garcia M, Perez-Ballestero R, Ding L, Duan L, Boise L, Thompson C, Noenez G: Bcl-XL is the major Bcl-S mRNA form expressed during murine development and its product localized to mitochondria. Development 120: 3033-3042, 1994.
179. Krajewski W, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC: Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membrains. Cancer Res 53: 4701-4717, 1993.
180. Zha H, Fisk HA, Yaffe MP, Mahajan N, Herman B, Reed JC: Structure-function comparison of the proapoptotic protein BAX in yeast and mammaliar cells. Mol Cell Biol 16: 6094-6508, 1996.
181. Hsu Y-T, Wolter KG, Youle R: Cytosol-to-membrane redistribution of Bax and Bcl-XL during apoptosis. Proc Natl Acad Sci USA 94: 3668-3672, 1997.
182. Walker NI: Ultrastructure of the rat pancreas after experimental duct ligation. I. The role of apoptosis and intraepithelial macrophages in acinar cell deletion. Am J Pathol 126: 439451, 1987.
183. Mandal M, Adam L, Mendelsohn J, Kumar R: Nuclear targeting of Bax during apoptosis in human colorectal cancer cells. Oncogene 17: 999-1007, 1998.
184. Gross A, Jockel J, Wei MC, Korsmeyer SJ: Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 14: 3878-3885, 1998.
185. Goping IS, Gross A, Lavoie JN, Nguyen M, Jemmerson R, Roth K, Korsmyer SJ, Shore GC: Regulated targeting of BAX to mitochondria. J Cell Biol 143: 207-215, 1998.
186. Rosse T, Olivier R, Monney L, Rager M, Conus S, Fellay I, Jansen B. Borner C: Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391: 496-9, 1998.
187. Putcha GV, Deshmukh M, Johnson EM, jr,: BAX translocation is a critical event in neuronal apoptosis: regulation by neuroprotectants, Bcl-2, and caspases. J Neurosci 19: 7476-7485, 1999.
188. Martin LJ: Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J Neuropathol Exp Neurol 58: 459-71, 1999.
189. Roy N, Mahadevan MS, McLean M, et al.: The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80: 167-178, 1995.
190. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A, Korneluk RG: Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379: 349-353, 1996.
191. Clem RJ and Duckett CS: The iap genes: unique arbitrators of cell death. Trends Cell Biol 7: 337-9, 1997.
192. Coovert DD, Le IT, McAndrew PE, Strasswimmer J, Craford TO, Mendell JR, Coulson SE, Androphy EJ, Prior TW, Burghes AHM: The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 6: 1205-14, 1997.
193. Stewart H, Wallace A, McGaughran J, Mountford R, Kingston H: Molecular diagnosis of spinal muscular atrophy. Arch Dis Child 78: 531-5, 1998.
194. Liu Q, Drefiss G: A novel nuclear structure containing the survival of motor neurons protein. EMBO J 15: 3555-65, 1996.
195. Liu Q, Fischer U, Wang F, Drefuss G: The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 90: 1013-21, 1997.
196. Fischer U, Liu Q, Drefuss G: The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 90: 1023-9, 1997.
197. Iwahashi H, Eguchi Y, Yasuhara N, Hanafusa T, Matsuzawa Y and Tsujimoto Y: Synergistic anti-apoptotics activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature 390: 413-417, 1997.
198. Ellis RE, Jacobson DM, Horvitz HR: Genes required for the engulfment of cell corpses during programmed cell death in Caenorhabditis clegans. Genetics 129: 79-94, 1991.
199. Milligan CE, Cunningham TJ, Levitt P: Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brain. J Comp Neurol 314: 125-135, 1991.
200. Hume DA, Perry VH, Gordon S: Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglia cells to form a regular array in the layers. J Cell Biol 97: 253-257, 1983.
201. Milligan CE, Levit P, Cunningham TJ: Brain macrophages and microglia respond differently to lesions of the developing and adult visual system. J Comp Neurol 314: 136-146, 1991.
202. Milligan CE, Prevette D, Yahinuma H, Homma S, Cardwell C, Fritz LC, Tomaselli KJ, Oppenheim RW, Schwartz LM: Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron 15: 385-393, 1995.
203. Wang X, Yue T-I, Barone FC, Feuerstein GZ: Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex. Stroke 26: 661-666, 1995.
204. Harrison, JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, Adhikari S, Thompson DA, Botti P, Bacon KB, Feng L: Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. PNAS 95: 10896-10901, 1998.
205. Savill J: Recognition and phagocytosis of cells undergoing apoptosis. British Med Bul 53: 491-508, 1997.
206. Pittman R and Oppenheim RW: Neuromuscular blockade increases motoneuron survival during normal cell death in the chick embryo. Nature 277: 364-366, 1978.
207. Oppenheim RW and Nunez R: Electrical stimulation of hindlimb increases neuronal cell death in chick embryos. Nature 295: 57-59, 1982.
208. Franklin JL and Johnson jr EM: Suppression of programmed neuronal death by sustained elevation of cytoplasmic calcium. TINS 15: 501-508, 1992.
209. Frade JM and Barde YA: Nerve growth factor: two receptors, multiple functions. Bioessays 20: 137-45, 1998.
210. Bibel M, Hoppe E, Barde YA. Biochemical and functional interactions between the neurotrophin receptors trk and p75 (NTR). EMBO J 18: 616-22, 1999.
211. Bamji SX, Majdan M, Pozniak CD, Belliveau DJ, Aloyz R, Kohn J, Causing CG, Miller FD: The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occuring sympathetic neuron death. J Cell Biol 140: 911-23, 1998.
212. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959-62, 1994.
213. Dobrowsky RT, Wemer MH, Castellino AM, Chao MV, Hannun YA: Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 265: 1596-9, 1994.
214. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV: Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383: 716-9, 1996.
215. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas andinitiates apoptosis. Cell 81: 505-12, 1995.
216. Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME, Dixit VM: FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 277: 4961-5, 1996.
217. Duan H and Dixit VM: RAIDD is a new 'death' adaptor molecule. Nature 385: 86-9, 1997.
218. Sakurai M, Hayashi T, Abe K, Sadahiro M, Tabayashi K: Delayed selective motor neuronal death and fas antigen induction after spinal cord ischemia in rabbits. Brain Res 797: 23-8, 1998.
219. Cheema ZF, Wade SB, Sata M, Walsh K, Sohrabji F, Miranda RC: Fas/Apo (Apoptosis)-1 and associated proteins in the differentiating cerebral cortex: induction of caspase-dependent cell death and activation of NF-kB. J Neurosci 19: 1754-1770, 1999.
220. Sabelko-Downes KA, Cross AH, Russell JH: Dual role for fas ligand in the initiation of and recovery from expeimental allergic encephalomyelitis. J Exp Med 189: 1195-205, 1999.
221. Martin-Villalba A, Herr I, Jeremais I, Hahme M, Brandt R, Vogel J, Schenkel J, Herdegen T Debatin KM: CD95 ligand (Fas-L-APO-1L) and tumor necrosis factor-related apoptosis- inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 19: 3809-17, 1999.
222. Oppenheim RW: Programmed Cell Death. In: Fundamental Neuroscience (Zigmond MJ, Bloom FE, Landis SC, Roberts JL, Squire LR, eds). New York, Academic Press, 1999, pp 581-609.
223. Lesser B and Bruchovsky N: The effect of testosterone, 5-alpha-dihydrotestosterone and adenosine 3′,5′-monophosphate on cell proliferation and differentiation in rat prostate. Biochem Biophys Acta 308: 426437, 1973.
224. Kerr J and Searle J: Deletion of cells by apoptosis during castration-induced involution of the rat prostate. Virchows Arch B Cell Pathol 13: 87-102, 1973.
225. Colombel M, Olsson CA, Ng P, and Buttyan R: Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Research 52: 4313-4319, 1992.
226. Rubin LL, Philpott KL, Brooks SF: The cell cycle and cell death. Curr Biol 3: 3914, 1993.
227. Yan G and Ziff EB; NGF regulates the PC12 cell cycle machinery through specific inhibition of the cdk kinases and induction of cyclin D1. J Neurosci 15: 6200-6212, 1995.
228. Kranenburg O, van der Eb AJ, Zantema A: Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J 15: 46-54, 1996.
229. Giardina SF, Cheung NS, Reid MT, and Beart PM: Kainate-induced apoptosis in cultured murine cerebellar granule cells elevates expression of the cell cycle gene cyclin D1. J Neurochem 71: 1325-1328, 1998.
230. Timsit S, Rivera S, Ouaghi P, Guischard F, Tremblay E, Ben-Ari Y, and Khrestchatisky: Increased cyclin D1 in vulnerable neurons in the hippocampus after ischaemia and epilepsy: a modulator of in vivo programmed .cell death? Eur J Neurosci 11: 263-278, 1999.
231. Farinelli SE and Greene LA: Cell cycle blockers mimosine, ciclopirox, and deferoxamine prevent the death of PC12 cells and postmitotic sympathetic neurons after removal of trophic support. J Neurosci 16: 1150-1162, 1996.
232. Hendry IA: Cell division in the developing sympathetic nervous system. J Neurocytol 6: 299-309, 1977.
233. Maas JW, Horstmann S, Borasio GD, Anneser JMH, Shooter EM, and Kahle PJ: Apoptosis of central and peripheral neurons can be prevented with cyclin-dependent kinase/mitogen- activated protein kinase inhibitors. J Neurochem 70: 1401-1410, 1998.
234. Sadoul R, Quiquerez AL, Martinou I, Fernandez PA, Martinou JC: p53 protein in sympathetic neurons: cytoplasmic localization and no apparent function in apoptosis. J Neurosci Res 43: 594-601, 1996.
235. Weissner C, Brink I, Lorenz P, Neuman-Haefelin T, Vogel P, and Yamashita K: Cyclin D1 messenger RNA is induced in microglia rather than neurons following transient forebrain ischaemia. Neurosci 72: 947-958, 1996.
236. Philpott KL, McCarthy MJ, Becker D, Gatchalian C, and Rubin LL: Morphological and biochemical changes in neurons: apoptosis versus mitosis. Eur J Neurosci 8: 1906-1915, 1996.